Location: Home
  • search
  • go
  • Relate News
  • 8/26/2019SMEI: Top Chemical Drug Products in Urban Chinese Retail Pharmacies 20...
  • 8/26/2019IQVIA: Overall Chinese Pharma Market Growth Slowed to 4.5% in 2018
  • 8/26/2019Review of Chinese Drug Evaluation and Registration in 2018
  • 8/26/2019Review of Chinese Pharma Deals, R&D and Regulatory Developments in...
  • 8/23/2019Chi-Med Initiates Phase I Trial of HMPL-523 for Immune Thrombocytopeni...
  • 8/23/2019111 Signs Strategic Partnership with TK.CN to Empower PBM and Insuranc...
  • 8/23/2019China to Step Up Crackdown on Drug Monopoly to Keep Prices and Supply ...
  • 8/21/2019China's Biopharma Strategy: Challenge or Complement to U.S. Industry C...
  • 8/21/2019Innovent Enters a Licensing Agreement with Lilly to Develop & ...
  • 8/21/2019Alligator Bio and Biotheus Enter Antibody Agreement for Greater China
  • 8/21/2019USFDA Grants Priority Review to BeiGene's Zanubrutinib in Patients wit...
  • 8/21/2019CMAB and Kintor Announce a New Partnership to Develop and Manufacture ...
  • 8/20/2019China's Central Government Introduces Major Policy Incentives and Rest...
  • 8/20/2019Chronic and Aging-related Diseases Cost Over Half of Chinese BMI Spend...
  • 8/19/2019NMPA Issues the Administrative Measures for Drug Quality Sampling Insp...
  • 8/19/2019CitiResearch - China at Inflection Point: Big Opportunity for MNCs, Do...
  • 8/19/2019Sanofi Gains Chinese IND Approval for RNAi Therapy Fitusiran Injection
  • 8/16/2019Regulator Penalizes 22 at Kangmei for $12.6 Billion of Overstatements
  • 8/16/2019China to Enhance Common Medicine Supply through New Measures
  • 8/16/2019Sun Pharma Expands Partnership with CMS for Generic Drugs in Mainland ...
  • 8/16/2019How to Use China's 2019 Negative Lists
  • 8/14/2019China Has Become A CEO-Level Priority for MNC Cos: Trend and Implicati...
  • 8/14/2019Sinohealth Projects Lower Chinese Pharmaceutical Market Growth in 2019
  • 8/14/2019CSL Maintains Positive China Business Outlook Despite Short Term Headw...
  • 8/13/2019IQVIA Market Prognosis Projects 4.8% CAGR for Chinese Pharmaceutical M...
  • 8/13/2019NHC Releases List of Trial Site Cities of Urban Medical Consortium Exp...
  • 8/13/2019State Council Introduces New Policy with Healthcare Reform Provisions
  • 8/12/2019CASI Pharmaceuticals Announces Launch of EVOMELA (melphalan for inject...
  • 8/12/2019Nanjing King-Friend to Invest US$95M in Injectable Specialist Meitheal...
  • 8/12/2019SMEI: Review of Chinese Terminal Drug Markets in 2010-H1/2019
  • Page:134/357 Total number of articles:10695: [First][<<] [132] [133] [134] [135] [136] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group